Funder: Breakthrough T1D
Due Dates (Anticipated): July 2026 (Full Proposals)
Funding Amounts: Up to $200,000/year (including indirect costs) for up to 5 years; not generally renewable after 5 years.
Summary: Supports early-career clinical researchers pursuing patient-oriented type 1 diabetes research, helping them transition to independent careers.
Key Information: Applications focused on long-term complications are not accepted; psychosocial and behavioral health projects are welcome.